D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
PUT
Skyworks Solutions
SWKS
$9.06B
| $9.59M | 0.01% |
116,300
-65,300
| -36% | -$5.04M |
|
|
TYPE
1102
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $9.55M | 0.01% |
480,061
+137,836
| +40% | +$2.48M |
|
1103
CALL
MetLife
MET
$61B
| $9.53M | 0.01% |
223,900
+131,700
| +143% | +$5.82M |
|
|
PPL
1104
PPL Corp
PPL
$27.3B
| $9.52M | 0.01% |
300,075
-1,098,778
| -79% | -$34.2M |
|
|
WBT
1105
DELISTED
Welbilt, Inc.
WBT
| $9.52M | 0.01% |
581,395
+539,806
| +1,298% | +$7.88M |
|
|
VSTO
1106
DELISTED
Vista Outdoor Inc.
VSTO
| $9.51M | 0.01% |
1,187,247
+84,358
| +8% | +$825K |
|
1107
CBIZ
CBZ
$2.29B
| $9.5M | 0.01% |
469,337
+33,738
| +8% | +$682K |
|
|
LSI
1108
DELISTED
Life Storage, Inc.
LSI
| $9.49M | 0.01% |
146,394
+59,766
| +69% | +$3.83M |
|
1109
Toro Company
TTC
$8.93B
| $9.46M | 0.01% |
137,397
-45,391
| -25% | -$2.88M |
|
1110
Ingevity
NGVT
$2.55B
| $9.46M | 0.01% |
+89,543
| New | +$9M |
|
1111
Logitech
LOGI
$15.2B
| $9.44M | 0.01% |
239,994
+32,028
| +15% | +$1.15M |
|
1112
Wave Life Sciences
WVE
$1.12B
| $9.43M | 0.01% |
242,644
+117,353
| +94% | +$4.76M |
|
1113
Anika Therapeutics
ANIK
$199M
| $9.42M | 0.01% |
311,608
+150,115
| +93% | +$5.14M |
|
1114
Scotiabank
BNS
$106B
| $9.37M | 0.01% |
175,826
+170,127
| +2,985% | +$9.32M |
|
|
ERF
1115
DELISTED
Enerplus Corporation
ERF
| $9.34M | 0.01% |
1,113,578
+513,100
| +85% | +$4.41M |
|
1116
CALL
Regeneron Pharmaceuticals
REGN
$68.8B
| $9.32M | 0.01% |
22,700
+800
| +4% | +$329K |
|
1117
Axos Financial
AX
$5.45B
| $9.3M | 0.01% |
320,981
+119,878
| +60% | +$3.59M |
|
|
IBKC
1118
DELISTED
IBERIABANK Corp
IBKC
| $9.29M | 0.01% |
129,578
+76,862
| +146% | +$5.71M |
|
|
ICPT
1119
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.24M | 0.01% |
82,600
+35,300
| +75% | +$3.86M |
|
1120
Enviri
NVRI
$621M
| $9.24M | 0.01% |
458,292
+300,984
| +191% | +$6.48M |
|
1121
1-800-Flowers.com
FLWS
$245M
| $9.23M | 0.01% |
506,337
+53,885
| +12% | +$868K |
|
1122
Cincinnati Financial
CINF
$28.3B
| $9.2M | 0.01% |
107,041
-1,592
| -1% | -$131K |
|
1123
CALL
BP
BP
$113B
| $9.19M | 0.01% |
213,745
+151,323
| +242% | +$6.2M |
|
1124
Hilltop Holdings
HTH
$2.29B
| $9.15M | 0.01% |
501,438
-70,432
| -12% | -$1.31M |
|
1125
ArcBest
ARCB
$3.44B
| $9.13M | 0.01% |
296,488
+15,459
| +6% | +$558K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.